US2013039994A1PendingUtilityA1

Low dose colonic cleansing system

60
Individually held — no corporate assignee on recordPriority: Aug 17, 2006Filed: Aug 20, 2012Published: Feb 14, 2013
Est. expiryAug 17, 2026(~0.1 yrs left)· nominal 20-yr term from priority
Inventors:Michael L. Caswell
A61K 33/42A61P 1/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of colonic cleansing that includes administering orally a first dose and a second dose of a liquid osmotic colonic evacuant composition. The second dose includes an amount of the liquid osmotic colonic evacuant composition that is 55% to 95% of the amount of the first dose.

Claims

exact text as granted — not AI-modified
1 . A method of colonic cleansing, comprising:
 administering orally a first dose of a liquid osmotic colonic evacuant composition; and   administering orally a second dose of the liquid osmotic colonic evacuant composition,   wherein the second dose comprises an amount of the liquid osmotic colonic evacuant composition that is 55% to 95% of the amount of the first dose of the liquid osmotic colonic evacuant composition.   
     
     
         2 . A method of  claim 1 , wherein the liquid osmotic colonic evacuant composition comprises a phosphate cathartic. 
     
     
         3 . The method of  claim 2 , wherein the phosphate cathartic comprises monobasic sodium phosphate and dibasic sodium phosphate. 
     
     
         4 . The method of  claim 1 , wherein the second dose comprises an amount that is 60% to 80% of the amount of the first dose. 
     
     
         5 . The method of  claim 3 , wherein the first dose of the phosphate cathartic comprises from 15 to 25 g monobasic sodium phosphate and from 5.5 to 9.4 g dibasic sodium phosphate. 
     
     
         6 . The method of  claim 3 , wherein the first dose of the phosphate cathartic comprises 20 to 23 g monobasic sodium phosphate and 7.5 to 8.6 g dibasic sodium phosphate. 
     
     
         7 - 9 . (canceled) 
     
     
         10 . The method of  claim 3 , further comprising mixing the phosphate cathartic with a flavorant and a sweetener. 
     
     
         11 . The method of  claim 3 , wherein the phosphate cathartic comprises a concentrate. 
     
     
         12 . (canceled) 
     
     
         13 . The method of  claim 3 , further comprising waiting at least three hours between administering the first dose and the second dose. 
     
     
         14 . A kit for colonic cleansing, comprising:
 a first dose of an osmotic colonic evacuant composition, and   a second dose of the osmotic colonic evacuant composition,   wherein the second dose comprises an amount of the osmotic colonic evacuant composition that is 55% to 95% of the amount of the first dose of the osmotic colonic evacuant composition, and   the osmotic colonic evacuant is not in the form of tablets or capsules.   
     
     
         15 . A kit of  claim 14 , wherein the osmotic colonic evacuant composition comprises a phosphate cathartic. 
     
     
         16 . The kit of  claim 15 , wherein the phosphate cathartic comprises monobasic sodium phosphate and dibasic sodium phosphate. 
     
     
         17 . The kit of  claim 14 , wherein the second dose comprises an amount that is 60% to 80% of the amount of the first dose. 
     
     
         18 . The kit of  claim 16 , wherein the first dose of the phosphate cathartic comprises from 15 to 25 g monobasic sodium phosphate and from 5.5 to 9.4 g dibasic sodium phosphate. 
     
     
         19 . The kit of  claim 16 , wherein the first dose of the phosphate cathartic comprises 20 to 23 g monobasic sodium phosphate and 7.5 to 8.6 g dibasic sodium phosphate. 
     
     
         20 - 22 . (canceled) 
     
     
         23 . The kit of  claim 16 , wherein the first dose and the second dose of the phosphate cathartic are in a single sealed container. 
     
     
         24 . The kit of  claim 16 , wherein the first dose and the second dose of the phosphate cathartic are in separate sealed containers. 
     
     
         25 . The kit of  claim 16 , further comprising a flavorant and a sweetener. 
     
     
         26 . (canceled) 
     
     
         27 . The kit of  claim 16 , wherein the phosphate cathartic comprises powder. 
     
     
         28 - 31 . (canceled) 
     
     
         32 . The kit of  claim 16 , further comprising a dosage container. 
     
     
         33 . (canceled) 
     
     
         34 . A kit for colonic cleansing, comprising:
 an osmotic colonic evacuant composition; and   at least one dosage container,   wherein the at least one dosage container has markings to denote a first dose and a second dose, and   the second dose comprises an amount that is 55% to 95% of the amount of the first dose.   
     
     
         35 . The kit of  claim 34 , wherein osmotic colonic evacuant composition comprises a phosphate cathartic. 
     
     
         36 . The kit of  claim 34 , wherein the phosphate cathartic comprises monobasic sodium phosphate and dibasic sodium phosphate. 
     
     
         37 . The kit of  claim 34 , wherein the second dose comprises an amount that is 60% to 80% of the amount of the first dose. 
     
     
         38 . The kit of  claim 36 , further comprising a flavorant and a sweetener. 
     
     
         39 - 42 . (canceled)

Join the waitlist — get patent alerts

Track US2013039994A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.